MRI INTERVENTNS ROE 2010-2019 | MRIC

Current and historical return on equity (ROE) values for MRI INTERVENTNS (MRIC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. MRI INTERVENTNS ROE for the three months ending March 31, 2019 was -190.89%.
MRI INTERVENTNS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.01B $0.00B -250.00%
2018-12-31 $-0.01B $0.00B -184.62%
2018-09-30 $-0.01B $0.00B -164.71%
2018-06-30 $-0.01B $0.00B -127.27%
2018-03-31 $-0.01B $0.01B -103.70%
2017-12-31 $-0.01B $0.01B -140.00%
2017-09-30 $-0.01B $0.01B -215.38%
2017-06-30 $-0.01B $0.01B -514.29%
2017-03-31 $-0.01B $-0.00B 600.00%
2016-12-31 $-0.01B $-0.00B 450.00%
2016-09-30 $-0.01B $0.00B 355.56%
2016-06-30 $-0.01B $-0.00B 125.00%
2016-03-31 $-0.01B $-0.00B 133.33%
2015-12-31 $-0.01B $-0.00B 177.78%
2015-09-30 $-0.01B $-0.01B 225.00%
2015-06-30 $-0.01B $-0.01B 288.89%
2015-03-31 $-0.01B $-0.00B 282.35%
2014-12-31 $-0.01B $0.00B 125.00%
2014-09-30 $-0.01B $-0.01B 86.96%
2014-06-30 $-0.00B $-0.01B 76.19%
2014-03-31 $-0.00B $-0.00B 63.16%
2013-12-31 $-0.01B $-0.01B 155.56%
2013-09-30 $-0.00B $-0.01B 84.21%
2013-06-30 $-0.00B $-0.00B 84.21%
2013-03-31 $-0.00B $-0.00B 59.26%
2012-12-31 $-0.01B $-0.01B 63.16%
2012-09-30 $-0.01B $-0.01B 69.23%
2012-06-30 $-0.01B $-0.01B 69.57%
2012-03-31 $-0.01B $-0.01B 102.86%
2011-12-31 $-0.01B $-0.02B 145.45%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.045B $0.007B
MRI Interventions Inc. operates as a medical device company. It develops platforms for invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging. The company focuses on research and product development in the field of interventional magnetic resonance imaging. MRI Interventions Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.416B 28.09
Medtronic (MDT) Ireland $143.383B 20.13
Stryker (SYK) United States $81.532B 28.19
Boston Scientific (BSX) United States $59.201B 28.72
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $31.224B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.323B 18.13
Coloplast (CLPBY) Denmark $26.860B 42.88
Lonza Group Ag (LZAGY) Switzerland $26.257B 0.00
Terumo (TRUMY) Japan $23.378B 26.88
Smith & Nephew SNATS (SNN) United Kingdom $20.390B 0.00
ResMed (RMD) United States $19.442B 37.07
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.146B 54.39
Canopy Growth (CGC) Canada $9.436B 0.00
Insulet (PODD) United States $9.187B 544.39
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $6.980B 20.81
Haemonetics (HAE) United States $6.855B 51.73
Perrigo (PRGO) Ireland $6.412B 11.81
Aurora Cannabis (ACB) Canada $6.033B 59.30
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.550B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.748B 62.34
ICU Medical (ICUI) United States $3.408B 22.10
NuVasive (NUVA) United States $3.354B 26.74
Hutchison China MediTech (HCM) China $2.694B 0.00
Quidel (QDEL) United States $2.542B 25.24
Agios Pharmaceuticals (AGIO) United States $2.526B 0.00
National Vision Holdings (EYE) United States $2.185B 47.17
Cardiovascular Systems (CSII) United States $1.757B 0.00
Aphria (APHA) $1.569B 0.00
Phibro Animal Health (PAHC) United States $1.321B 19.79
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.030B 23.73
Omeros (OMER) United States $1.004B 0.00
NanoString Technologies (NSTG) United States $0.966B 0.00
PetIQ (PETQ) United States $0.929B 21.95
Lantheus Holdings (LNTH) United States $0.899B 23.64
Eagle Pharmaceuticals (EGRX) United States $0.795B 20.26
Cerus (CERS) United States $0.762B 0.00
MacroGenics (MGNX) United States $0.749B 0.00
Quanterix (QTRX) United States $0.691B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.625B 118.74
LeMaitre Vascular (LMAT) United States $0.618B 36.66
OraSure Technologies (OSUR) United States $0.451B 20.86
Meridian Bioscience (VIVO) United States $0.415B 12.95
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.403B 0.00
United Health Products (UEEC) United States $0.392B 0.00
BioLife Solutions (BLFS) United States $0.391B 128.44
Utah Medical Products (UTMD) United States $0.348B 25.50
Zynex (ZYXI) United States $0.327B 34.76
Owens & Minor (OMI) United States $0.310B 9.28
Bovie Medical (APYX) United States $0.258B 0.00
Vapotherm (VAPO) United States $0.237B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.150B 0.00
Female Health (VERU) United States $0.119B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 21.24
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.012B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00